Here’s an academic abstract based on the provided summary and keywords:

**Abstract:**

Recent advances in plasma biomarker analysis offer promising avenues for early Alzheimer’s disease detection. However, significant biological variation within individual samples presents a considerable challenge to data interpretation. This study examines the extent of this variation across multiple plasma biomarkers in 2023.  Addressing this inherent variability is crucial for establishing robust diagnostic thresholds and facilitating personalized therapeutic strategies targeting Alzheimer’s disease progression.